5 Stocks to Buy According to Mark McMeans’ Brasada Capital Management

4. Danaher Corporation (NYSE:DHR)

Brasada Capital Management’s Stake Value: $15,044,000
Percentage of Brasada Capital Management’s 13F Portfolio: 3.37%
Number of Hedge Fund Holders: 82

Danaher Corporation (NYSE:DHR), founded in 1969 and based in Washington, manufactures, designs, and markets professional, industrial, medical, and commercial products and services. Brasada Capital Management reduced its stake in Danaher Corporation (NYSE:DHR) by 5% in Q2 2022, holding about 59,341 shares worth $15.04 million, representing 3.37% of the total securities.

On August 24, Credit Suisse analyst Dan Leonard commenced coverage of Danaher Corporation (NYSE:DHR), rating the stock as ‘Outperform’ with a price target of $340. The analyst concluded that after the epidemic, the firm had become stronger.

Ken Fisher’s Fisher Asset Management is a prominent shareholder of Danaher Corporation (NYSE:DHR) as of Q2 2022, with 3.84 million shares worth $973.27 million. Another notable stakeholder of Danaher Corporation (NYSE:DHR) is Dan Loeb’s Third Point, with 2.30 million shares of the company. Overall, 82 hedge funds in the database of Insider Monkey owned positions in Danaher Corporation (NYSE:DHR) at the end of June, with a collective stake value of $4.84 billion.

In its Q2 2022 investor letter, Weitz Investment Management mentioned Danaher Corporation (NYSE:DHR). Here is what the fund said:

“Consistent with that approach, portfolio activity among our long holdings tilted toward purchases. We added to almost half our holdings by varying degrees, and we were pleased to initiate new positions in Danaher (NYSE:DHR). Danaher is a provider of instruments and diagnostic tools to medical, life science, and other desirable end-markets worldwide. The business generate significant free cash flow, possess strong competitive positions, and have excellent management teams with demonstrated acquisition records.”